FDA Approved: DABIGATRAN ETEXILATE — Supplemental Application (XLCare Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approves a supplemental application for XLCare Pharmaceuticals to market a generic dabigatran etexilate, covering its approved indications for preventing st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Deep Vein Thrombosis
• Nonvalvular Atrial Fibrillation
• Pulmonary Embolism

Drugs mentioned

• Dabigatran etexilate (Dabigatran etexilate)

Snippet

SUPPL AP for DABIGATRAN ETEXILATE (DABIGATRAN ETEXILATE)